KOAN (Resonate Blends) OCF Margin %: -124.79% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Resonate Blends OCF Margin %?

Resonate Blends KOAN OCF Margin % is -124.79% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 964 Drug Manufacturers companies, Resonate Blends ranks worse than 91.39% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Resonate Blends's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.30 Mil. Resonate Blends's Revenue for the three months ended in Mar. 2026 was $0.24 Mil. Therefore, Resonate Blends's OCF Margin % for the quarter that ended in Mar. 2026 was -124.79%.

As of today, Resonate Blends's current OCF Yield % is -317.92%.

The historical rank and industry rank for Resonate Blends's OCF Margin % or its related term are showing as below:

KOAN' s OCF Margin % Range Over the Past 10 Years
Min: -10303.7   Med: -71.74   Max: 68.75
Current: -79.25

During the past 13 years, the highest OCF Margin % of Resonate Blends was 68.75%. The lowest was -10303.70%. And the median was -71.74%.

KOAN's OCF Margin % is ranked worse than
91.39% of 964 companies
in the Drug Manufacturers industry
Industry Median: 10.025 vs KOAN: -79.25

Resonate Blends OCF Margin % Related Terms

Resonate Blends OCF Margin % Historical Data

* Premium members only.

The historical data trend for Resonate Blends's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resonate Blends OCF Margin % Chart

Resonate Blends Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10,303.70 -2,856.00 68.75 -54.27 -89.20

Resonate Blends Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.49 -54.76 -54.87 0.00 -124.79

KOAN vs PTPI, KAYS, OWPC: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonate Blends OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Resonate Blends's OCF Margin % falls into.


Resonate Blends OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Resonate Blends's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.519/1.703
=-89.20 %

Resonate Blends's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.302/0.242
=-124.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -124.79% mean?
Resonate Blends (KOAN) has a OCF Margin % of -124.79% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Resonate Blends and its competitors. According to the industry distribution chart, Resonate Blends ranks #881 out of 964 companies in the Drug Manufacturers industry, placing it in the top 91.4%.
Is Resonate Blends' OCF Margin % too high?
Resonate Blends' current OCF Margin % is -124.79%. Based on the distribution chart, Resonate Blends ranks #881 out of 964 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Resonate Blends' OCF Margin % compare to PTPI and KAYS?
According to the Drug Manufacturers industry distribution chart, Resonate Blends ranks #881 out of 964 companies for OCF Margin %. This places Resonate Blends in the lower half of its industry. The industry median OCF Margin % is 10.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.03, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Resonate Blends and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonate Blends's current OCF Margin % is -124.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonate Blends stock overvalued right now?
Resonate Blends (KOAN) has a current OCF Margin % of -124.79%. The current OCF Margin % is -124.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Resonate Blends (KOAN), the current OCF Margin % is -124.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Resonate Blends Business Description

Address One Marine Plaza, Suite 305A, North Bergen, NJ, USA, 04047
Resonate Blends Inc is engaged in the discovery, development, and marketing of nutritionally designed regenerative medicine and wellness products. The company focuses on natural stem cell mobilizing agents, diet aids, and bioactive formulations intended to enhance human performance and support health and wellness for consumer and professional markets.